Table 1.

Relationships between TCF21 expression and clinicopathological features of the ESCC patients.

Characteristics	Low	High	Total (n)	P-value
Age (years)				0.644
≥60	16	14	30
<60	24	26	50
Gender				0.228
Male	30	25	55
Female	10	15	25
Differentiation				0.52
G1	6	10	16
G2	28	24	52
G3	6	6	12
T stage				0.975
T1	8	9	17
T2	8	7	15
T3	15	16	31
T4	9	8	17
N stage				0.024*
N0	21	22	43
N1	8	16	24
N2	7	2	9
N3	4	0	4
Clinical stage				0.758
I	7	9	16
II	15	16	31
III	18	15	33

χ² test. Significant value: P<0.05.